GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Cash Received from Insurance Activities

Amicogen (XKRX:092040) Cash Received from Insurance Activities


View and export this data going back to 2013. Start your Free Trial

What is Amicogen Cash Received from Insurance Activities?

Cash Received from Insurance Activities only applicable to companies reporting Cash Flow from Operations in direct method.


Amicogen (XKRX:092040) Business Description

Industry
Traded in Other Exchanges
N/A
Address
1259-64, Dongbu-ro, Gyeongsangnam-do, Jinseong-myeon, KOR, 660-852
Amicogen, Inc. is an industrial biotechnology company operating in Korea. It is engaged in development, production and distribution of enzymes, bio new materials and healthcare food. The company's products portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP) and protein A chromatography resins.